Our colleague, Axel Haack, was given the great opportunity to showcase the GBA Group Pharma laboratories and secondly he visited GBA Pharma Labs (part 2/5).

With the acquisition of the Swedish company Key2Compliance AB, GBA Group is expanding its range of consulting and training services for the medical device, In Vitro Diagnostics (IVD), and pharmaceutical industry. GBA Group is thus taking another important step towards establishing itself as a broad service provider for international customers in this area.

Our colleague, Axel Haack, was given the great opportunity to showcase the GBA Group Pharma laboratories and he started with Pharmacelsus (Part 1/5).

On Sept. 26, 2023, Dr. Sabine Gorynia, EVP GBA Group Pharma & Medical Devices, Torben Giese, Chief Strategy Officer GBA Group, and Felix Bunde, Managing Director GBA MDS, visited the new colleagues at ICCR Roßdorf GmbH.

"Global efforts in the area of health care will continue to grow in the future. With this in mind, GBA Group has significantly expanded its Pharma & Medical Devices portfolio and will continue to invest in this growth market to position itself as a professionally comprehensive and internationally positioned laboratory and service provider for the benefit of our society." Steffen Walter, CEO.